Phase
Condition
Asthma
Treatment
Therapeutic bronchoscopy for removal of mucus plugs
Clinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Protocol A:
Inclusion Criteria:
Males or females between the ages 18 to 70 at the time of visit 1.
Clinical history of asthma per patient report or medical record.
Pre-bronchodilator FEV1 < 80% predicted and ≥ 35% predicted
CT mucus plug score > 5.
Written informed consent obtained from subject and ability for subject to complywith the requirements of the study.
Exclusion
Exclusion Criteria:
Smoking of tobacco or other recreational inhalants in the last month and/or >10pack-year smoking history.
History of other pulmonary disorders including cystic fibrosis and COPD (ChronicObstructive Pulmonary Disease).
History of unstable cardiovascular disease.
BMI > 45
Current use of anticoagulant medications.
Upper Respiratory Infection (URI) within the previous 6 weeks
Currently pregnant and/or unwillingness to practice medically acceptable birthcontrol or complete abstinence during the study
History of COVID-19 (coronavirus disease) in the past 6 months.
Protocol B:
Inclusion Criteria:
Males or females between the ages 18 to 80 at the time of visit 1.
Undergoing clinically indicated bronchoscopy for removal of mucus plugs.
Clinical history of airway disease (including asthma, COPD and bronchiectasis) perpatient report or medical record.
Written informed consent obtained from subject.
Exclusion Criteria:
Upper Respiratory Infection (URI) in the past 30 days.
History of COVID-19 in the past 30 days.
Currently pregnant during the study.
Study Design
Study Description
Connect with a study center
UCSF Airway Clinical Research Center
San Francisco, California 94143
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.